Delivery Order SPE2DB22D2103-SPE2DB24FR9NR

Award Date 6/21/24
Potential Completion Date 6/24/24
Potential Value $55K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,632.62 firm fixed price delivery order is for the supply of 4567445213 - MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,566.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product, with a completion date of February 10, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,905.74 firm fixed-price delivery order is for the supply of MOVANTIK 12.5 MG TABLET 30S, with a completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a...
This federal contract award, identified as SPE2DB20D2104|SPE2DB23FV03H, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,622.16 fixed-price delivery order is for the supply of 4561934977 - MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of August 25, 2023 and was awarded on August 24, 2023. It does not have a set-aside designation,...
This is a $6,470.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The order has an ultimate completion date of August 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, a Delivery Order valued at $9,110.52, is for the provision of MOVANTIK 12.5 MG TABLET 30S, a medical product. The contract has an ultimate completion date of May 19, 2023 and uses a Firm Fixed Price pricing type. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc.,...
This federal contract award SPE2DB20D1109|SPE2DB25FN00X, valued at $9,076.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the medication MOVANTIK 25 MG TABLET 30S and has a completion date of October 31, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOVANTIK 25 MG TABLET 30S. The contract has a firm fixed price of $1,177.53 and a completion date of June 27, 2025. The contract is not set aside and was awarded on June 26, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,510.92, is for the delivery of the pharmaceutical product Movantik 12.5 mg tablet, with an ultimate completion date of April 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order award to Amerisourcebergen Drug Corp under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The specific order is for the pharmaceutical product MOVANTIK 25 MG TABLET 30S, with a firm fixed price of $1,327.18 and a completion date of August 6, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, was awarded this order as part of its extensive IDC...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB24FR9NR
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $54,934.15 firm fixed-price delivery order is for the supply of MOVANTIK 25 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of June 24, 2024 and was awarded on June 21, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and the award demonstrates the company's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.

Generated 5/17/25, 9:45 AM